Page last updated: 2024-12-07

methanesulfinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Methanesulfinic acid is a colorless, hygroscopic solid. It is a strong acid, with a pKa of 1.8. Methanesulfinic acid is a versatile reagent that can be used to synthesize a wide variety of sulfur-containing compounds. For example, it can be used to synthesize sulfoxides, sulfones, and sulfonic acids. Methanesulfinic acid is also an important intermediate in the synthesis of various pharmaceuticals and agrochemicals. Methanesulfinic acid has been shown to have a number of biological effects. For example, it has been shown to inhibit the growth of certain types of cancer cells. However, methanesulfinic acid is also known to be toxic, and it should be handled with care. The study of methanesulfinic acid is important because it is a useful reagent for the synthesis of a wide variety of sulfur-containing compounds. It is also important to understand the biological effects of methanesulfinic acid, in order to ensure its safe use.'

methanesulfinic acid: structure given in first source; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

methanesulfinic acid : An organosulfinic acid that is methane in which one of the hydrogens has been replaced by a sulfino group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID87251
CHEBI ID133897
MeSH IDM0151010

Synonyms (15)

Synonym
methanesulfinic acid
inchi=1/ch4o2s/c1-4(2)3/h1h3,(h,2,3
methylsulfinic acid
17696-73-0
CHEBI:133897
methanesulphinic acid
methane sulfinic acid
C21398
DTXSID50170227
AKOS030229087
DTXSID80902396
noname_1638
methanesulfinic acid (6ci,8ci,9ci)
EN300-42802
methanesulfinicacid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The excretion of methanesulfinic acid increased about ninefold and that of methanesulfonic doubled when rats were dosed with 17 mumol of pentachlorothioanisole."( Isotope dilution assay for urinary methanesulfinic and methanesulfonic acids: application to detection of methylthio turnover.
Bakke, JE; Feil, VJ; Zaylskie, RG, 1989
)
0.61
" The effect of t-butanol addition and ozone gas flow dosage on the degradation rate was evaluated."( Degradation of DMSO by ozone-based advanced oxidation processes.
Chen, SH; Muruganandham, M; Wu, JJ, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organosulfinic acidOrganic derivatives of sulfinic acid in which the sulfino group is linked directly to carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (22.73)18.7374
1990's8 (36.36)18.2507
2000's6 (27.27)29.6817
2010's3 (13.64)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.64 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]